For: | Ren YJ, Zhang QY. Expression of midkine and its clinical significance in esophageal squamous cell carcinoma. World J Gastroenterol 2006; 12(13): 2006-2010 [PMID: 16610048 DOI: 10.3748/wjg.v12.i13.2006] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v12/i13/2006.htm |
Number | Citing Articles |
1 |
Yingying Xu, Xiujuan Qu, Xue Zhang, Yang Luo, Ye Zhang, Ying Luo, Kezuo Hou, Yunpeng Liu. Midkine positively regulates the proliferation of human gastric cancer cells. Cancer Letters 2009; 279(2): 137 doi: 10.1016/j.canlet.2009.01.024
|
2 |
Hideaki Shimada, Satoshi Yajima, Yoko Oshima, Takaki Hiwasa, Masatoshi Tagawa, Kazuyuki Matsushita, Fumio Nomura. Impact of serum biomarkers on esophageal squamous cell carcinoma. Esophagus 2012; 9(3): 131 doi: 10.1007/s10388-012-0332-x
|
3 |
Shuichi Fujita, Sachiko Seki, Mutsunori Fujiwara, Tohru Ikeda. Midkine expression correlating with growth activity and tooth morphogenesis in odontogenic tumors. Human Pathology 2008; 39(5): 694 doi: 10.1016/j.humpath.2007.09.014
|
4 |
Minakshi Saikia, Nathan Cheung, Abhay Kumar Singh, Vaishali Kapoor. Role of Midkine in Cancer Drug Resistance: Regulators of Its Expression and Its Molecular Targeting. International Journal of Molecular Sciences 2023; 24(10): 8739 doi: 10.3390/ijms24108739
|
5 |
|
6 |
Luo Zhang, Xing Song, Yingjie Shao, Changping Wu, Jingting Jiang. Prognostic value of Midkine expression in patients with solid tumors: a systematic review and meta-analysis. Oncotarget 2018; 9(37): 24821 doi: 10.18632/oncotarget.23892
|
7 |
Tamina Rawnaq, Miriam Kunkel, Kai Bachmann, Ronald Simon, Hilke Zander, Stephan Brandl, Guido Sauter, Jakob R. Izbicki, Jussuf T. Kaifi. Serum Midkine Correlates with Tumor Progression and Imatinib Response in Gastrointestinal Stromal Tumors. Annals of Surgical Oncology 2011; 18(2): 559 doi: 10.1245/s10434-010-1191-0
|
8 |
Xing Yao, Fu-Chu Qian, Li-Cheng Dai, Li-Shan Min. Preparation and Preliminary Characterization of Rabbit Monoclonal Antibodies Against Human Midkine. Hybridoma 2011; 30(1): 87 doi: 10.1089/hyb.2010.0076
|
9 |
Yujie Zhang, Zhaowei Meng, Mingfang Zhang, Jian Tan, Weijun Tian, Xianghui He, Qiang Fu, Ke Xu, Qing He, Mei Zhu, Xue Li, Guizhi Zhang, Yajing He, Qiang Jia, Jianping Zhang, Sheng Wang, Xinghua Song. Immunohistochemical evaluation of midkine and nuclear factor-kappa B as diagnostic biomarkers for papillary thyroid cancer and synchronous metastasis. Life Sciences 2014; 118(1): 39 doi: 10.1016/j.lfs.2014.09.025
|
10 |
Tang Deng, Qifeng Huang, Kaiwen Lin, Jin Qian, Qi Li, Lihua Li, Shuangqin Xu, Hongfang Yun, Hangfei Wang, Xinxin Wu, Heng Liu, Guiyun Jin, Xiaoran Liu. Midkine-Notch2 Pathway Mediates Excessive Proliferation of Airway Smooth Muscle Cells in Chronic Obstructive Lung Disease. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.794952
|
11 |
M. Krzystek-Korpacka, M. Matusiewicz, D. Diakowska, K. Grabowski, K. Blachut, I. Kustrzeba-Wojcicka, T. Banas. Serum midkine depends on lymph node involvement and correlates with circulating VEGF-C in oesophageal squamous cell carcinoma. Biomarkers 2007; 12(4): 403 doi: 10.1080/13547500701192470
|
12 |
Kojiro Tanabe, Mitsuyo Matsumoto, Shinya Ikematsu, Satoru Nagase, Atsushi Hatakeyama, Tadao Takano, Hitoshi Niikura, Kiyoshi Ito, Kenji Kadomatsu, Shin‐ichi Hayashi, Nobuo Yaegashi. Midkine and its clinical significance in endometrial carcinoma. Cancer Science 2008; 99(6): 1125 doi: 10.1111/j.1349-7006.2008.00796.x
|
13 |
Kazuma Sakamoto, Kenji Kadomatsu. Midkine in the pathology of cancer, neural disease, and inflammation. Pathology International 2012; 62(7): 445 doi: 10.1111/j.1440-1827.2012.02815.x
|
14 |
Amira A. Hammam, Dina H. El Dahshan, Hassan M. Metwally, Mohamed A. El Feky. The expression of Midkine gene in patients with acute myeloid leukemia and its significance. Comparative Clinical Pathology 2014; 23(3): 749 doi: 10.1007/s00580-013-1680-1
|
15 |
Bruno Correia Jham, Nadia Lago Costa, Janine Mayra Silva, Alessandra Castro de Miranda, Jose Carlos Oliveira, Tarcília Aparecida Silva, Aline Carvalho Batista. Midkine expression in oral squamous cell carcinoma and leukoplakia. Journal of Oral Pathology & Medicine 2012; 41(1): 21 doi: 10.1111/j.1600-0714.2011.01049.x
|
16 |
Panagiota S. Filippou, George S. Karagiannis, Anastasia Constantinidou. Midkine (MDK) growth factor: a key player in cancer progression and a promising therapeutic target. Oncogene 2020; 39(10): 2040 doi: 10.1038/s41388-019-1124-8
|
17 |
S Maeda, H Shinchi, H Kurahara, Y Mataki, H Noma, K Maemura, K Aridome, T Yokomine, S Natsugoe, T Aikou, S Takao. Clinical significance of midkine expression in pancreatic head carcinoma. British Journal of Cancer 2007; 97(3): 405 doi: 10.1038/sj.bjc.6603879
|
18 |
Yiyan Zhai, Jingyuan Zhang, Zhihong Huang, Rui Shi, Fengying Guo, Fanqin Zhang, Meilin Chen, Yifei Gao, Xiaoyu Tao, Zhengsen Jin, Siyu Guo, Yifan Lin, Peizhi Ye, Jiarui Wu. Single-cell RNA sequencing integrated with bulk RNA sequencing analysis reveals diagnostic and prognostic signatures and immunoinfiltration in gastric cancer. Computers in Biology and Medicine 2023; 163: 107239 doi: 10.1016/j.compbiomed.2023.107239
|
19 |
M. Ruan, T. Ji, Z. Wu, J. Zhou, C. Zhang. Evaluation of expression of midkine in oral squamous cell carcinoma and its correlation with tumour angiogenesis. International Journal of Oral and Maxillofacial Surgery 2007; 36(2): 159 doi: 10.1016/j.ijom.2006.09.004
|
20 |
Zong-li Qi, Xi-jin Xu, Bao Zhang, Zhong-ying Shen, Xia Huo. Esophageal carcinoma 109 cell line is found positive in HPV type 18. Diseases of the Esophagus 2007; 20(4): 362 doi: 10.1111/j.1442-2050.2007.00753.x
|
21 |
Tai-Jan Chiu, Yi-Ju Chen, Kun-Ming Rau, Chang-Han Chen, Chih-Yen Chien, Shau-Hsuan Li, Hsin-Ting Tsai, Hock-Liew Eng. Midkine neurite growth-promoting factor 2 expression as a potential prognostic marker of adjuvant therapy in head and neck squamous cell carcinoma. Biomarkers 2013; 18(8): 687 doi: 10.3109/1354750X.2013.846412
|
22 |
Ming-Chun Ma, Yi-Ju Chen, Tai-Jan Chiu, Jui Lan, Chien-Ting Liu, Yi-Ching Chen, Hsin-Ho Tien, Yen-Yang Chen. Positive expression of Midkine predicts early recurrence and poor prognosis of initially resectable combined hepatocellular cholangiocarcinoma. BMC Cancer 2018; 18(1) doi: 10.1186/s12885-018-4146-7
|